Prolonged SARS-CoV-2 Risk Varies Across Immunosuppressive Conditions

WEDNESDAY, Jan. 31, 2024 -- The risk for prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) varies across immunosuppressive conditions, according to a study published in the Jan. 24 issue of Science Translational Medicine.
Yijia...

Source: Drugs.com - Pharma News - January 31, 2024 Category: Pharmaceuticals Source Type: news